This highlights the importance of considering CYP24A1 variants not only in younger individuals with classic symptoms, but also in older patients who may exhibit mild or atypical signs, such as unexplained hypercalcemia, nephrocalcinosis, or kidney stones. This evidence concerns the gene CYP24A1 and nephrocalcinosis.